Education
  • Featured content
    Sally Hodder, MD, reviews the factors clinicians should consider in making the optimal use of PIs in the clinical management of HIV.
  • Featured content
    In this Expert Analysis, Joseph J. Eron, Jr., MD; Joel E. Gallant, MD, MPH; and Andrew R. Zolopa, MD, provide an in-depth review of the most clinically relevant new data presented at the 2014 Conference on Retroviruses and Opportunistic Infections on the management of HIV and other key topics, along with downloadable slides.
  • Featured content
    Richard E. Chaisson, MD, and Maunank Shah, MD, discuss the intricacies of management of multidrug resistance in tuberculosis, including new approaches to diagnosis and identification of resistance, treatment with current and newer agents, and investigations into preventive strategies.
  • Featured content
    In this Interactive Case Challenge, Monica Gandhi, MD, MPH, leads you through key decisions in the selection and management of first-line therapy for a patient who is marginally housed and food insecure.
  • Featured content
    Joseph J. Eron, Jr., MD, reviews clinical trial data and provides expert commentary on the current role of the newest antiretroviral drug class in HIV treatment of naive and experienced patients.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Educational Activities

10 of 397 Shown
10 of 397 Shown
Show 10 More
Loading...